Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.840
-0.220 (-10.68%)
Dec 5, 2025, 4:00 PM EST - Market closed
Artelo Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1.72 | 2.34 | 2.82 | 6.89 | 12.16 | 6.63 | Upgrade
|
| Short-Term Investments | - | - | - | 1.5 | - | - | Upgrade
|
| Trading Asset Securities | - | - | 7.61 | 9.15 | 11.95 | 3.44 | Upgrade
|
| Cash & Short-Term Investments | 1.72 | 2.34 | 10.43 | 17.53 | 24.11 | 10.07 | Upgrade
|
| Cash Growth | -64.59% | -77.58% | -40.53% | -27.29% | 139.57% | 369.89% | Upgrade
|
| Prepaid Expenses | 0.11 | 0.22 | 0.55 | 0.79 | 0.5 | 0.25 | Upgrade
|
| Total Current Assets | 1.83 | 2.56 | 10.98 | 18.32 | 24.61 | 10.32 | Upgrade
|
| Property, Plant & Equipment | 0.07 | 0.1 | 0.02 | 0.06 | 0.08 | 0.09 | Upgrade
|
| Long-Term Investments | - | - | - | - | 1.52 | - | Upgrade
|
| Other Intangible Assets | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | Upgrade
|
| Other Long-Term Assets | 0.33 | 0 | 0 | 0 | 0 | 0.19 | Upgrade
|
| Total Assets | 4.27 | 4.7 | 13.04 | 20.42 | 28.25 | 12.64 | Upgrade
|
| Accounts Payable | 3.87 | 1.68 | 1.24 | 0.91 | 0.98 | 0.47 | Upgrade
|
| Accrued Expenses | 0.08 | 0.06 | 0.03 | 0.05 | 0.02 | 0.01 | Upgrade
|
| Short-Term Debt | 0.88 | - | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.03 | Upgrade
|
| Other Current Liabilities | - | -0 | - | - | - | 0.02 | Upgrade
|
| Total Current Liabilities | 4.86 | 1.77 | 1.29 | 1 | 1.03 | 0.53 | Upgrade
|
| Long-Term Leases | 0.04 | 0.07 | - | 0.02 | 0.06 | 0.07 | Upgrade
|
| Total Liabilities | 4.9 | 1.84 | 1.29 | 1.02 | 1.08 | 0.59 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 58.49 | 53.19 | 52.26 | 50.68 | 48.12 | 28.93 | Upgrade
|
| Retained Earnings | -58.85 | -50.14 | -40.31 | -31.02 | -20.94 | -16.9 | Upgrade
|
| Comprehensive Income & Other | -0.28 | -0.2 | -0.2 | -0.25 | -0.02 | 0.02 | Upgrade
|
| Shareholders' Equity | -0.63 | 2.86 | 11.75 | 19.4 | 27.17 | 12.04 | Upgrade
|
| Total Liabilities & Equity | 4.27 | 4.7 | 13.04 | 20.42 | 28.25 | 12.64 | Upgrade
|
| Total Debt | 0.95 | 0.1 | 0.02 | 0.06 | 0.09 | 0.1 | Upgrade
|
| Net Cash (Debt) | 0.77 | 2.23 | 10.4 | 17.47 | 24.03 | 9.97 | Upgrade
|
| Net Cash Growth | -83.86% | -78.53% | -40.45% | -27.28% | 140.97% | 365.45% | Upgrade
|
| Net Cash Per Share | 1.16 | 4.16 | 21.09 | 37.00 | 64.64 | 48.05 | Upgrade
|
| Filing Date Shares Outstanding | 2.02 | 0.55 | 0.54 | 0.48 | 0.47 | 0.47 | Upgrade
|
| Total Common Shares Outstanding | 1.56 | 0.55 | 0.53 | 0.48 | 0.47 | 0.27 | Upgrade
|
| Working Capital | -3.03 | 0.79 | 9.69 | 17.32 | 23.58 | 9.79 | Upgrade
|
| Book Value Per Share | -0.41 | 5.22 | 22.11 | 40.77 | 57.80 | 44.19 | Upgrade
|
| Tangible Book Value | -2.67 | 0.82 | 9.71 | 17.36 | 25.13 | 10 | Upgrade
|
| Tangible Book Value Per Share | -1.72 | 1.50 | 18.27 | 36.48 | 53.46 | 36.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.